相关实验视频
Updated: Jun 11, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.5K
关于定义喘表型的炎症生物标志物的最新情况
Soyoon Sim1, Youngwoo Choi2, Hae-Sim Park3
1Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Allergy, asthma & immunology research
|October 4, 2024
概括
识别新的生物标志物是分类喘亚型和改善患者管理的关键. 这篇综述探讨了酸性,中性和严重喘的新标志物,帮助个性化治疗策略.
科学领域:
- 肺病学和呼吸系统医学
- 临床免疫学临床免疫学
- 生物标志物发现发现
背景情况:
- 喘是一种复杂的慢性呼吸道疾病,患者表现和潜在机制各异.
- 精确的喘表型和内型的分类对于有效的个性化治疗和预测结果至关重要.
- 当前的诊断生物标志物虽然有用,但有局限性,需要识别新型标志物.
研究的目的:
- 审查最近识别的生物标志物来分类不同的喘表型/内型.
- 讨论2型高喘 (eosinophilic) 和2型低喘 (neutrophilic) 的新生物标志物.
- 探索非类固醇抗炎药物恶化呼吸道疾病和严重喘的生物标志物.
主要方法:
- 最近临床试验和研究研究的文献综述.
- 对喘分类所识别的生物标志物的分析.
- 综合关于生物标志物在患者管理中的有用性信息.
主要成果:
- 已经出现了几种新的生物标志物来区分喘亚型.
- 这些生物标志物为埃索诺菲尔性,中性恋性和严重喘提供了改进的分类.
- 新兴生物标志物在指导有针对性的治疗干预方面表现有前途.
结论:
- 新的生物标志物对于完善喘表型和内型是至关重要的.
- 这些进步促进了更精确的患者分类和个性化的管理策略.
- 对新型生物标志物的进一步研究将加强对不同喘群体的治疗.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241
Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
358
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
358

